BioSpace News Archive

Drug Development

Inovio Receives Milestone Payment From MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squamous Cell Cancer Advances to Phase II

First efficacy trial to evaluate Inovio’s cancer immunotherapy targeting HPV in combination with durvalumab.

January 8, 2018
·
7 min read
Business

Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue

In addition, the Company appointed Keith Sullivan as interim General Manager of miraDry, a Sientra subsidiary.

January 8, 2018
·
7 min read
Drug Development

Alder Announces Eptinezumab Significantly Reduces Migraine Risk Meets Primary and All Key Secondary Endpoints in Pivotal PROMISE 2 Phase III Trial for Chronic Migraine Prevention

The primary endpoint met: reduction of 8.2 monthly migraine days from baseline compared to 5.6 days for placebo.

January 8, 2018
·
12 min read
Alimera Sciences Refinances Debt With New $40M Debt Facility From Solar Capital

Elimination of liquidity covenants frees working capital to fuel company growth.

January 8, 2018
·
5 min read
Business

Profound Medical Corp. Announces Preliminary Fourth Quarter 2017 Revenue and Provides Progress Update on TACT Pivotal Trial Patient Enrollment

Profound anticipates total revenues for the fourth quarter of 2017 to be approximately $1.9 million.

January 8, 2018
·
5 min read
Business

Sanifit Announces the Appointment of Cris Calsada as CFO

Ms. Calsada joins Sanifit with over 20 years of corporate finance and executive experience in the life sciences and technology industries.

January 8, 2018
·
2 min read
Deals

Zymergen Acquires Metagenomics Company Radiant Genomics

Zymergen today announced the acquisition of Radiant Genomics, a leader in functional metagenomics research.

January 8, 2018
·
3 min read
Biotech Bay

Biotricity Expands its R&D Effort to Capitalize on Artificial Intelligence

Properly executed this could lead to an improvement in detection quality and patient outcomes while driving down costs and potentially providing another product opportunity for Biotricity.

January 8, 2018
·
5 min read
Lone Star Bio

Miraca Life Sciences Announces Company Name Change to Inform Diagnostics

Miraca Life Sciences announced today that it has changed its name to Inform Diagnostics effective immediately.

January 8, 2018
·
2 min read
Deals

Microbot Medical Enters Into Agreement to Acquire Novel Technology to Enhance Existing Technology Platforms and Strengthen Patent Portfolio

he acquisition is expected to close within 90 days, at which time, with the The addition of CadioSerts’ issued U.S. patent and three patent applications pending worldwide, Microbot would have a patent portfolio of 25 issued/allowed patents and 15 patent applications pending worldwide.

January 8, 2018
·
6 min read